spacer
The Healthcare Sales & Marketing Network celebrates 24 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  binary restenosis 

 HSMN NewsFeed - 22 May 2013
OrbusNeich's Genous(TM) Stent Associated With Lower Restenosis Rate Compared to Bare Metal Stents in Low-Risk Non-ST-Segment Elevation Acute Coronary Syndrome (NSTE-ACS) Patients
Devices Interventional Cardiology
 HSMN NewsFeed - 20 May 2013
OrbusNeich's Genous(TM) Stent Associated With Lower Restenosis Rate Compared to Bare Metal Stents in Low-Risk Non-ST-Segment Elevation Acute Coronary Syndrome (NSTE-ACS) Patients
Devices Interventional Cardiology
 HSMN NewsFeed - 28 Aug 2012
Elixir Medical Receives CE Mark Approval for the DESyne(R) BD Novolimus Eluting Coronary Stent System With Biodegradable Polymer Coating
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 16 May 2012
Elixir Medical Announces Excellent Results from DESolve I First-In-Man Study for the Fully Bioresorbable Drug Eluting Coronary Scaffold System
Devices Interventional Cardiology
 HSMN NewsFeed - 15 May 2012
Elixir Medical Announces Continued Excellent One Year Safety and Efficacy Data from the EXCELLA BD Randomized Clinical Trial for DESyne BD(TM) Novolimus Eluting Coronary Stent with Biodegradable Polymer
Devices Interventional Cardiology
 HSMN NewsFeed - 4 Apr 2011
BIOTRONIK Announces Positive 6-month Results for Pantera(R) Lux Paclitaxel Releasing Balloon
Devices Interventional Cardiology
 HSMN NewsFeed - 21 Jun 2010
Data Show OrbusNeich's Genous Bio-engineered R stent is Safe and Effective in Combination with Drug-Eluting Balloon
Devices Interventional Cardiology
 HSMN NewsFeed - 25 May 2010
NEVO Sirolimus-eluting Coronary Stent Continues to Demonstrate Excellent Safety and Efficacy Outcomes in New Twelve-Month Data
Devices Interventional Cardiology
 HSMN NewsFeed - 9 Nov 2009
VIVA 2009 Late-Breaking Trials Highlight Advances in Interventional Treatments of Peripheral Arterial Disease
Devices Interventional
 HSMN NewsFeed - 19 May 2009
NEVO Sirolimus-Eluting Coronary Stent Yields Superior Results to Taxus Liberte Stent in Pivotal Clinical Trial
Devices Interventional Cardiology
 HSMN NewsFeed - 15 Dec 2008
FDA Approves Boston Scientific's Express(R) SD Renal Stent System
Devices Interventional FDA
 HSMN NewsFeed - 13 Oct 2008
12-Month ATLANTA Trial Data Show Sustained Benefit of Catania(TM) Stent in Treatment of De Novo Coronary Lesions
Devices Interventional Cardiology
 HSMN NewsFeed - 13 May 2008
XTENT Announces Positive Six-Month CUSTOM III Trial Data Presented at EuroPCR Meeting
Devices Interventional Cardiology
 HSMN NewsFeed - 1 Apr 2008
TAXUS(R) Stent Demonstrates Similar Outcomes in Diabetic Patients Compared to Non-diabetics in Pooled Analysis of TAXUS IV and V Trials
Devices Interventional Cardiology
 HSMN NewsFeed - 1 Apr 2008
Elixir Medical Announces Positive Nine-Month Results From the Excella Novolimus-Eluting Coronary Stent System First-In-Man Study
Devices Interventional Cardiology
 HSMN NewsFeed - 31 Mar 2008
Spirit II Results Support Strength of Boston Scientific's Two Drug-Eluting Stent Platforms
Devices Interventional Cardiology
 HSMN NewsFeed - 31 Mar 2008
SPIRIT II Explores Long-Term Performance of XIENCE V Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 21 Jan 2008
Super-Thin Drug-Free Coating 'Hides' Stent as It Unblocks Heart Arteries
Devices Interventional Cardiology
 HSMN NewsFeed - 20 Jan 2008
CeloNova BioSciences Introduces a New Class of Coronary Stent: The CATANIA(TM) Coronary Stent System with NanoThin Polyzene(R)-F
Devices Interventional Cardiology
 HSMN NewsFeed - 24 Oct 2007
Drug Eluting Balloons Show Promise as a Potential Alternative to Drug Eluting Stents Used in the Treatment of Coronary Artery Disease
Devices Interventional Cardiology
 HSMN NewsFeed - 25 Sep 2007
Abbott Initiates Clinical Study to Evaluate Use of RX Herculink(R) Elite(TM) Renal Stent System for the Treatment of Renal Artery Stenosis
Devices Interventional
 HSMN NewsFeed - 22 May 2007
XTENT Announces Promising Six-Month Custom II Trial Data Presented at EuroPCR Meeting
Devices Interventional Cardiology
 HSMN NewsFeed - 22 May 2007
Medtronic Announces Positive Nine-Month Results for Endeavor(R) Resolute Next Generation Drug-Eluting Stent at EuroPCR
Devices Interventional Cardiology
 HSMN NewsFeed - 22 May 2007
Abbott Announces Continued Positive Results with XIENCE(TM) V Everolimus Eluting Coronary Stent in SPIRIT Clinical Trials
Devices Interventional Cardiology
 HSMN NewsFeed - 13 Apr 2007
CINVENTION and Relisys Medical Devices Enroll First Patients in Clinical Trial of the Corel + C Drug-Eluting Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 25 Oct 2006
Medtronic Announces Positive Results for Endeavor RESOLUTE Drug-Eluting Coronary Stent System
Devices Interventional Cardiology
 HSMN NewsFeed - 5 Sep 2006
Abbott's XIENCE V(TM) Drug-Eluting Coronary Stent Superior to TAXUS(R) Stent in SPIRIT II Clinical Trial
Devices Interventional Cardiology
 HSMN NewsFeed - 21 Aug 2006
Circulation Article Reports That Medtronic's Endeavor(R) Drug-Eluting Stent Provides Further Evidence of Effective, Safe and Sustained Clinical Outcomes
Devices Interventional Cardiology
 HSMN NewsFeed - 18 May 2006
Conor Medsystems Announces First Patient Treated with Dual-Drug Coronary Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 16 May 2006
Xtent CUSTOM I Trial Shows Zero Restenosis, Favorable Late Loss Results at Eight Months
Devices Interventional Cardiology
 HSMN NewsFeed - 11 May 2006
Conor Medsystems Initiates RAPID Clinical Study for First Pimecrolimus Drug-Eluting Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 20 Apr 2006
Conor Medsystems Completes Enrollment of COSTAR II Pivotal Randomized Drug-Eluting Stent Trial
Devices Interventional Cardiology
 HSMN NewsFeed - 12 Mar 2006
New Data Suggest Differences in Clinical Performance Between the CYPHER(R) Sirolimus-Eluting Coronary Stent and the Taxus Stent in Long Complex Lesions
Devices Interventional Cardiology
 HSMN NewsFeed - 8 Mar 2006
New Clinical Data for the CYPHER(R) Sirolimus-Eluting Coronary Stent In Heart Attacks and Long Lesions to Appear At ACC
Devices Interventional Cardiology
 HSMN NewsFeed - 28 Feb 2006
Healing Stent Nine Month Mace Rate Similar to Drug Eluting Stents
Devices Interventional Cardiology
 HSMN NewsFeed - 2 Feb 2006
CYPHER(R) Sirolimus-Eluting Coronary Stent Outperforms Taxus Stent in Head-to-Head Small Vessel Clinical Trial
Devices Interventional Cardiology
Return to NewsFeed  

 Additional items found! 51

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 51 additional stories matching:
binary restenosis
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.